About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Clinical Trials in Ohio | 28,732 Studies Near You

Clinical TrialsOhio

Clinical Trials in Ohio

Discover 28,732 clinical trials near Ohio. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 5021-5040 of 28,732 trials

CompletedIndividualized Exercise Oncology Program for Newly Diagnosed Breast Cancer PatientsTo test the effect of an individualized exercise oncology program on healthcare utilization, 30-day hospital readmission, pain, and cancer treatment tolerance.NCT04106609·Dayton, Ohio RecruitingMirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or OverweightThe main purpose of this study is to evaluate the efficacy and safety of mirikizumab and placebo compared with mirikizumab and concomitantly administered tirzepatide in adult…NCT06937099·Dothan, Alabama and 182 others

Find Trials by Condition in Ohio

Breast Cancerin Ohio Lung Cancerin Ohio Prostate Cancerin Ohio Colorectal Cancerin Ohio Melanomain Ohio Leukemiain Ohio Lymphomain Ohio Pancreatic Cancerin Ohio Ovarian Cancerin Ohio Brain Cancerin Ohio Diabetesin Ohio

Data from ClinicalTrials.govTerms

CompletedSTRADIVARIUS (Strategy To Reduce Atherosclerosis Development InVolving Administration of Rimonabant - the Intravascular Ultrasound Study)The purpose of this study is to determine if rimonabant 20 mg once daily (od) administered during 18-20 months will reduce progression of coronary atherosclerosis as assessed by…NCT00124332·Cleveland, Ohio and 8 others

CompletedDecitabine as Maintenance Therapy After Standard Therapy in Treating Patients With Previously Untreated Acute Myeloid LeukemiaThis phase II trial is studying the side effects and how well decitabine works when given as maintenance therapy after standard therapy in treating patients with previously…NCT00416598·San Francisco, California and 45 others

RecruitingA Study of Sacituzumab Govitecan (IMMU-132) in Patients With Recurrent or Persistent Cervical CancerThis is a non-randomized Phase 2 study of sacituzumab govitecan (IMMU-132) in subjects with recurrent or persistent cervical cancer.NCT05838521·New Haven, Connecticut and 1 other

CompletedAudio and Video Brochures for Increasing Colorectal Cancer Screening Among Adults Living in AppalachiaThis clinical trial compares audio brochures and video brochures to usual care for increasing colorectal cancer (CRC) screening among adults living in Appalachia.NCT05810714·Columbus, Ohio

CompletedA Study Evaluating the Safety and Efficacy of ENV-101 (Taladegib) in Patients With Advanced Solid Tumors Harboring PTCH1 Loss of Function MutationsThis study employs a 2-stage design that aims to evaluate the efficacy and safety of ENV- 101, a potent Hedgehog (Hh) pathway inhibitor, in patients with refractory advanced solid…NCT05199584·Los Angeles, California and 15 others

CompletedAtacicept Phase 2/3 in Generalized Systemic Lupus Erythematosus (APRIL-SLE)This study is to evaluate the efficacy and safety of atacicept compared to placebo in preventing new flares in subjects with systemic lupus erythematosus (SLE) and to confirm the…NCT00624338·Birmingham, Alabama and 112 others

RecruitingPrism Adaptation Therapy (PAT) for Right Brain Stroke RehabilitationAfter a right brain stroke, \>50% of Veterans experience problems with dressing, eating, self-care or steering their wheelchairs because their ability to move, orient, and respond…NCT05983185·West Haven, Connecticut and 3 others

CompletedAdministration of Growth Hormone to Increase CD4+ Count in Patients Taking Anti-HIV DrugsThis study is designed to evaluate the ability of growth hormone (GH, also known as somatropin) to increase CD4+ cell counts in patients taking anti-HIV drugs.NCT00050921·Birmingham, Alabama and 12 others

CompletedLHRH Analogue Therapy With Enzalutamide or Bicalutamide in Treating Patients With Hormone Sensitive Prostate CancerThis randomized phase II trial studies if enzalutamide added to standard luteinizing hormone-releasing hormone (LHRH) analogue therapy will improve effects against prostate cancer…NCT02058706·Birmingham, Alabama and 3 others

CompletedLong-term Safety of Alogliptin in Patients With Type 2 Diabetes MellitusThe purpose of this study is to evaluate the long-term safety of alogliptin, once daily (QD), following participation in 1 of 7 controlled studies in patients with type 2 diabetes…NCT00306384·Birmingham, Alabama and 113 others

RecruitingStudy of ALTO-300 in MDDThe purpose of this study is to determine efficacy differences between ALTO-300 and placebo, used adjunctively to an antidepressant, related to patient characteristics.NCT05922878·Phoenix, Arizona and 44 others

Active not recruitingA Trial of Casdozokitug in Combination With Toripalimab Plus Bevacizumab in Participants With Unresectable and/or Locally Advanced or Metastatic Hepatocellular CarcinomaThe main goals of this study are to evaluate the safety and efficacy of casdozokitug in combination with toripalimab plus bevacizumab and to define a recommended dose for…NCT06679985·Scottsdale, Arizona and 43 others

RecruitingA Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood TransfusionsThe main aim of this study is to find out how well elritercept works in lowering the need for RBC transfusions.NCT06499285·Duarte, California and 176 others

CompletedA Study to Learn About the Safety of BIIB122 Tablets and Whether They Can Slow the Worsening of Early-Stage Parkinson's Disease in Adults Between the Ages of 30 and 80In this study, researchers will learn more about BIIB122 in participants with early-stage Parkinson's disease (PD).NCT05348785·Phoenix, Arizona and 112 others

CompletedStudy Evaluating the Pharmacokinetics of Doxylamine Succinate in ChildrenThe primary goal of this study is to characterize the pharmacokinetics of doxylamine succinate in children ages 2 to \< 18 years.NCT00796315·Washington D.C., District of Columbia and 5 others

CompletedThe Safety, Tolerability, PK and PD of GSK2586881 in Patients With Acute Lung InjuryThis is an early phase (phase IIa), randomized, multi-center study in subjects with acute lung injury (ALI) or acute respiratory distress syndrome (ARDS).NCT01597635·Sacramento, California and 18 others

CompletedExtension Study of Eculizumab in Patients With Transfusion Dependent Paroxysmal Nocturnal Hemoglobinuria (PNH)The purpose of this study is to evaluate the long-term safety of eculizumab in patients with transfusion dependent hemolytic PNH.NCT00122317·Stanford, California and 39 others

CompletedA Trial Assessing The Effectiveness and Safety of [S,S]-Reboxetine in Patients With FibromyalgiaThe purpose of this study is to assess the safety and effectiveness of \[S,S\]-Reboxetine in patients with fibromyalgia.NCT00357825·Chandler, Arizona and 60 others

PreviousPage 252 of 1437Next

Heart Diseasein Ohio